Economic experts agree anti-competitive S. 127 would increase Rx drug costs
In case you missed it, leading economic experts and competition watchdogs have overwhelmingly expressed concern with recently reintroduced legislation, S. 127, the Pharmacy Benefit Manager Transparency Act, that targets the pharmacy benefits of employers and small businesses.